Navigation Links
STAAR Surgical To Present At Wedbush And Canaccord Investor Conferences
Date:8/7/2014

MONROVIA, Calif., Aug. 7, 2014 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA) a leading developer, manufacturer and marketer of implantable lenses and delivery systems for the eye, today announced that management will present at the following investor conferences:

The Wedbush 2014 Life Sciences Management Access Conference at the Le Parker Meridien Hotel in New York on Tuesday, August 12 at 10:20 a.m. PT/1:20 p.m. ET

The Canaccord Genuity 34th Annual Growth Conference at the InterContinental Hotel in Boston on Wednesday, August 13 at 10:00 a.m. PT/1:00 p.m. ET

Barry Caldwell, President and CEO, Hans Blickensdoerfer, President, Europe, Middle East, Latin America, and Steve Brown, CFO will offer a general overview of the Company's current business trends, recent financial results, and operational developments. A live webcast, including accompanying slides, will be available from the Company's website, under Investor Information. An archived replay of management's presentations will be available for 90 days following the event, also at www.staar.com.

About STAAR SurgicalSTAAR, which has been dedicated solely to ophthalmic surgery for over 25 years, designs, develops, manufactures and markets implantable lenses for the eye and delivery systems therefor. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR's lens used in refractive surgery as an alternative to LASIK is called an Implantable Collamer® Lens or "ICL." A lens used to replace the natural lens after cataract surgery is called an intraocular lens or "IOL." More than 450,000 Visian ICLs have been implanted to date; to learn more about the ICL go to: www.visianinfo.com. STAAR has approximately 335 full time employees and markets lenses in over 60 countries. Headquartered in Monrovia, CA, it manufactures in Aliso Viejo, CA and Monrovia, CA. For more information, please visit the Company's website at www.staar.com.CONTACT:InvestorsMediaEVC Group

EVC GroupDoug Sherk

Nicole Kruse 415-652-9100

646-688-0425


'/>"/>
SOURCE STAAR Surgical Company
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. STAAR Surgical Reports 10% Second Quarter Revenue Growth
2. STAAR Surgical Moves Second Quarter Earnings Release and Conference Call One Day to July 31
3. STAAR Surgical Announces Second Quarter 2014 Results Release Date, Conference Call And Webcast
4. STAAR Surgical To Present At Piper Jaffray Healthcare Investor Conference
5. STAAR Surgical to Host Investor Breakfast and Webcast during the American Academy of Ophthalmologys Annual Meeting
6. STAAR Surgical Reports Continued Momentum During Third Quarter
7. STAAR Surgical Reports Strong Second Quarter Financial Results
8. STAAR Surgical Announces Second Quarter 2013 Results Release Date And Conference Call And Webcast
9. STAAR Surgical To Present At Upcoming Investor Conferences
10. STAAR Surgical Reports Strong First Quarter 2013 Financial Results
11. STAAR Surgical Provides Preliminary First Quarter Revenue Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2017)... Research and Markets has announced the addition ... their offering. ... devices market to grow at a CAGR of 6.35% during the ... 2017-2021, has been prepared based on an in-depth market analysis with ... its growth prospects over the coming years. The report also includes ...
(Date:4/18/2017)... and BLOOMINGTON, Minn. , April ... IMMY ) ("Imprimis"), an ophthalmology-focused pharmaceutical company, ... Lens"), today announced the signing of a three-year ... Lens will deploy a dedicated sales team to ... the U.S., primarily focused in 13 states in ...
(Date:4/18/2017)... 2017 Research and Markets has announced ... Molecular Imaging Equipment and Radiopharmaceuticals Market, Forecast to 2023" ... ... revenues as well as growth in the number of unit ... to market participants that design and manufacture molecular imaging equipment. ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol USA® ... introducing Flexadin UCII, part of the EQUISTRO line, at this week’s Rolex Kentucky ... horses at the immunologic level. , The scientifically-developed Flexadin UCII supports the body’s ...
(Date:4/24/2017)... ... April 24, 2017 , ... Michael Vick announced his retirement earlier ... position. The former overall number one pick in the 2001 NFL Draft, to the ... the record for the most career rushing yards by a quarterback (6,109) and the ...
(Date:4/24/2017)... ... April 24, 2017 , ... NEPC Director Kevin ... of Education Research Award. The award honors scholars exemplary in their capacity to ... scholar who has demonstrated the capacity to deepen the public’s understanding and appreciation ...
(Date:4/24/2017)... Seattle, Washington (PRWEB) , ... April 24, 2017 , ... ... T-Fal OptiGrill, Oxiclean, Space Bag, Sonicare Toothbrush, Juiceman Juicer, and the George Foreman Grill ... than perhaps any other marketer in the last 25 years. , Now, due to ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... that they are seeking public support to bring their novel lifesaving device for ... wearable device packed with medical-grade sensors, specially designed to read a child’s vital ...
Breaking Medicine News(10 mins):